Evidence mapPaperPMID 41899437Full record

ReviewCurrent issues in molecular biology2026

Autophagy: From Molecular Mechanisms to Disease Regulation and Therapeutic Strategies.

Huijie Yang, Xinyu Li, Kaidie Wang, Yujiao Zou, Quanjuan Shi, Ya Yang, Qingyun Zhao, Wei Zou

Abstract readReview
In one paragraph

Review in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Regulation of Innate Immune Signaling by Autophagy.International journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Huijie YangSchool of Public Health, Kunming Medical University, Kunming 650500, China.
Xinyu LiSchool of Public Health, Kunming Medical University, Kunming 650500, China.
Kaidie WangSchool of Public Health, Kunming Medical University, Kunming 650500, China.
Yujiao ZouSchool of Public Health, Kunming Medical University, Kunming 650500, China.
Quanjuan ShiSchool of Public Health, Kunming Medical University, Kunming 650500, China.
Ya YangSchool of Public Health, Kunming Medical University, Kunming 650500, China.
Qingyun ZhaoSchool of Public Health, Kunming Medical University, Kunming 650500, China.
Wei ZouSchool of Public Health, Kunming Medical University, Kunming 650500, China.

Funding

The Science and Technology Plan Project of the Science and Technology Department of Yunnan Province 202301AY070001-194
6 · The paper itself

Abstract

Autophagy is increasingly recognized as a context-dependent regulatory process that links cellular quality control with systemic metabolic and neurological homeostasis. However, how distinct autophagy pathways contribute to disease progression, and how they are dynamically modulated by host-microbiota interactions, remain incompletely understood. In this review, we synthesize recent advances in the molecular regulation of macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA), with a particular emphasis on selective autophagy and its disease-specific functions. We examine emerging evidence implicating autophagy as a bidirectional modulator in neurodegenerative and metabolic disorders, highlighting conditions under which autophagy exerts protective versus maladaptive effects. Importantly, we integrate recent findings on the microbiota-gut-brain axis to illustrate how microbial signals reshape autophagic responses and influence disease susceptibility and progression. Finally, we summarize current progress and limitations in autophagy-targeted therapeutic strategies, including nanomedicine-based delivery systems, and propose conceptual frameworks to guide the development of precise, context-aware autophagy interventions. This review provides an updated and integrative perspective that bridges molecular mechanisms, host-microbiota crosstalk, and translational opportunities in autophagy-related diseases.

Indexed as

autophagymetabolic disordersmicrobiota–gut–brain axismolecular mechanismsneurodegenerative diseasestherapeutic strategies

Identifiers

PMID41899437
PMCPMC13024834

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.